behavior
myelinogen
properti
glial
cell
well
document
follow
transplant
region
focal
experiment
demyelin
anim
model
howev
abil
glial
cell
prepar
remyelin
model
necessarili
indic
transplant
demyelin
lesion
clinic
diseas
success
one
preclud
factor
regard
greater
understand
environment
condit
support
transplantmedi
remyelin
studi
determin
whether
complex
reactiv
cn
environ
mous
hepat
viru
mhv
model
multipl
sclerosi
ms
could
support
transplantmedi
remyelin
striatal
neural
precursor
deriv
postnat
day
mice
commit
glial
cell
lineag
label
immunohistochem
stain
indic
popul
gener
glial
cell
follow
differenti
vitro
transplant
glialcommit
progenitor
cell
spinal
cord
mhvinfect
mice
demonstr
complet
hindlimb
paralysi
result
migrat
cell
mm
implant
site
remyelin
axon
transplantedremyelin
anim
contain
approxim
number
axon
within
sampl
region
ventral
later
column
compar
nontranspl
anim
suggest
remyelin
associ
axon
spare
furthermor
transplant
result
behavior
improv
studi
demonstr
first
time
transplantmedi
remyelin
possibl
pathogen
environ
mhv
demyelin
model
associ
locomotor
improv
remyelin
success
regen
event
within
adult
central
nervou
system
cn
restor
saltatori
conduct
smith
et
al
facilit
function
recoveri
jefferi
blakemor
remyelin
demonstr
varieti
experiment
demyelinationmut
model
blakemor
blakemor
blakemor
blakemor
duncan
et
al
gumpel
et
al
herndon
et
al
blakemor
jefferi
et
al
moor
et
al
rodriguez
et
al
sasaki
ide
yajima
suzuki
occur
spontan
natur
occur
demyelin
diseas
ms
prinea
et
al
howev
remyelin
failur
preval
success
consid
spectrum
patholog
affect
cn
although
remyelin
usual
success
anim
model
often
incomplet
theiler
model
demyelin
murray
et
al
furthermor
remyelin
less
effici
old
anim
young
anim
shield
et
al
failur
remyelin
illustr
within
foci
chronic
demyelin
within
later
stage
ms
prinea
et
al
chronic
ms
lesion
character
oligodendrocyt
loss
ozawa
et
al
remyelin
limit
border
inact
plaqu
suzuki
et
al
repair
persist
demyelin
may
amelior
clinic
deterior
addit
restor
normal
impuls
conduct
utzschneid
et
al
remyelin
may
decreas
axon
degenerationtransect
suggest
demonstr
chronic
demyelin
axon
vulner
degenerationtransect
axon
loss
later
stage
ms
contribut
clinic
deterior
bjartmar
et
al
de
stefano
et
al
find
underscor
import
develop
therapeut
strategi
enhanc
remyelin
one
approach
activ
enhanc
respons
endogen
mechan
repair
demonstr
follow
growth
factor
administr
experiment
autoimmun
encephalomyel
eae
demyelin
model
yao
et
al
passiv
transfer
antiserum
rodriguez
et
al
purifi
immunoglobulin
rodriguez
lennon
mice
immun
spinal
cord
homogen
theiler
demyelin
model
miller
rodriguez
altern
approach
remyelin
area
demyelin
transplant
remyelinationcompet
cell
stem
cell
neural
precursor
repres
attract
sourc
gener
remyelinationcompet
cell
readili
amplifi
differenti
oligodendrocyt
lineag
benhur
et
al
brustl
et
al
stem
cellderiv
glial
precursor
shown
myelin
follow
transplant
myelindefici
rat
brustl
et
al
neural
precursorderiv
glialcommit
progenitor
benhur
et
al
shown
myelin
follow
transplant
region
acut
experiment
demyelin
recent
intracerebroventricular
intrathec
implant
neural
precursor
eae
demyelin
model
result
migrat
transplant
cell
white
matter
differenti
astrocyt
oligodendrocyt
although
assess
abil
myelin
perform
benhur
et
al
determin
whether
transplant
repres
viabl
strategi
treat
demyelin
necessari
better
understand
rang
environment
condit
support
transplantationmedi
remyelin
studi
investig
abil
complex
reactiv
diseas
state
chronic
demyelin
mhv
model
ms
support
transplantmedi
remyelin
intracerebr
inject
strain
mhv
result
acut
encephalomyel
demyelin
follow
day
later
immunemedi
demyelin
encephalomyel
hindlimb
paralysi
progress
cn
destruct
includ
initi
new
demyelin
foci
probabl
life
mous
fleme
et
al
hare
perlman
lane
et
al
stohlman
hinton
stohlman
et
al
model
provid
environ
ongo
demyelin
pathogenesi
thu
distinct
gliotoxin
lesion
intraspin
transplant
glialcommit
progenitor
mhv
model
ms
result
extens
migrat
transplant
cell
robust
remyelin
axon
spare
behavior
improv
result
show
transplantmedi
remyelin
possibl
follow
intraspin
transplant
environ
ongo
pathogenesi
resembl
ms
striata
postnat
day
mice
dissect
tritur
maintain
previous
describ
benhur
et
al
trypan
blue
use
determin
cell
viabil
cell
grown
day
float
cluster
lowadher
plastic
dish
corn
life
scienc
acton
initi
densiti
ml
dmem
supplement
gibcoinvitrogen
carlsbad
ca
insulin
sodium
selenit
transferrin
putrescin
progesteron
detail
benhur
et
al
agml
epiderm
growth
factor
egf
sigmaaldrich
st
loui
mo
day
cultur
supernat
contain
float
cluster
remov
centrifug
g
min
cluster
resuspend
fresh
media
ad
new
cultur
dish
day
agml
egf
ad
cultur
dish
day
cluster
wash
resuspend
fresh
media
ad
new
cultur
dish
day
cluster
incub
mm
brdu
sigmaaldrich
cultur
medium
overnight
one
cultur
dish
label
brdu
compar
viabil
differenti
presenc
absenc
brdu
day
cultur
prepar
transplant
cluster
dissoci
trypsinedta
invitrogen
canada
inc
burlington
min
tritur
centrifug
min
g
resuspend
three
time
calciumand
magnesiumfre
dmem
gibcoinvitrogen
concentr
final
densiti
cell
al
media
cell
prepar
kept
ice
maximum
h
transplant
day
transplant
cell
prepar
immunocytochemistri
cluster
centrifug
min
g
resuspend
three
time
fresh
media
without
egf
plate
mgml
polyllysin
sigmaaldrich
agml
laminin
sigmaaldrich
coat
four
chamber
imag
slide
nalgenenunc
intern
rochest
ny
assess
differenti
potenti
cell
grown
imag
slide
adher
substrat
day
fix
paraformaldehyd
fisher
scientif
pittsburgh
pa
pb
min
immunocytochem
stain
perform
use
standard
protocol
imag
chamber
block
normal
goat
serum
ng
chemicon
temecula
ca
min
room
temperatur
primari
antibodi
polyclon
rabbit
antigalc
chemicon
dilut
ng
monoclon
mous
antineun
chemicon
dilut
ng
polyclon
rabbit
antigfap
dako
denmark
dilut
ng
monoclon
mous
anticd
b
serotec
uk
dilut
ng
polyclon
rat
antibrdu
accur
chemic
scientif
corpor
westburi
ny
dilut
ng
appli
imag
chamber
overnight
imag
chamber
rins
three
time
pb
incub
min
ng
fluorescentconjug
secondari
antibodi
alexa
goat
antirabbit
goat
antirat
goat
antimous
igg
hl
dilut
ng
vector
laboratori
burlingam
ca
appli
incub
h
room
temperatur
chamber
rins
three
time
pb
nuclear
stain
conduct
expos
cultur
bisbenzimid
hoechst
molecular
probe
eugen
min
cell
quantif
conduct
use
olympu
light
microscop
object
percentag
immunoposit
cell
determin
divid
total
number
immunoposit
cell
total
number
hoechstposit
cell
imag
chamber
averag
result
three
differ
imag
chamber
per
marker
total
hoechstposit
cell
count
analys
imag
slide
one
noprimari
control
chamber
three
stain
chamber
marker
mention
immunoposit
cell
clearli
hoechstposit
nucleu
count
agematch
weightmatch
g
male
mice
b
background
nation
cancer
institut
bethesda
md
n
anesthet
methoxyfluran
inhal
pitmanmoor
inc
washington
cross
nj
mice
receiv
intracerebr
inject
plaqu
form
unit
neurotrop
corona
viru
mhv
strain
kindli
provid
j
fleme
univers
wisconsin
madison
wi
suspend
al
steril
salin
lane
et
al
intracerebr
inject
mhv
result
biphas
diseas
acut
encephalomyel
myelin
loss
follow
day
later
immunemedi
demyelin
encephalomyel
hindlimb
paralysi
progress
destruct
cn
fleme
et
al
hare
perlman
lane
et
al
stohlman
et
al
two
mhv
inject
anim
die
first
week
post
inject
surviv
rate
anim
inject
viral
strain
anim
usual
die
first
day
acut
infect
anim
surviv
acut
stage
diseas
chanc
surviv
control
sham
anim
n
inject
al
steril
salin
alon
develop
behavior
histolog
deficit
twelv
day
mhv
intracerebr
inject
anim
n
receiv
singl
inject
cell
al
calciumand
magnesiumfre
dmem
gibcoinvitrogen
spinal
cord
use
protocol
describ
blakemor
crang
briefli
anim
anesthet
avertin
receiv
laminectomi
spinal
process
cranial
laminectomi
immobil
use
micromanipul
transplant
needl
hamilton
syring
hamilton
compani
reno
nv
siliconco
pull
glass
tip
lower
spinal
cord
use
stereotact
manipul
arm
cell
suspens
inject
one
site
midlin
spinal
cord
needl
remov
cord
min
inject
cell
complet
addit
six
control
anim
receiv
mhv
intracerebr
inject
receiv
transplant
one
anim
die
transplantationanesthesia
anim
randomli
select
inclus
either
group
receiv
incis
skin
overli
allow
blind
analys
durat
experi
behavior
test
anim
conduct
blind
observ
everi
day
use
clinic
score
scale
houtman
fleme
normal
limp
tail
waddl
gait
partial
hindlimb
weak
complet
hindlimb
paralysi
death
anim
scale
supplement
singl
increment
point
limp
tail
partial
waddl
gait
hindlimb
weak
hindlimb
weak
partial
hindlimb
paralysi
complet
hindlimb
paralysi
moribund
disposit
anim
acclim
behavior
test
day
mhv
inject
mhv
inject
anim
test
everi
day
transplant
anim
test
everi
day
week
everi
day
end
experi
statist
signific
determin
use
mann
whitney
u
test
anim
euthan
chloral
hydrat
anesthesia
fisher
scientif
day
follow
transplant
day
mhv
infect
fix
cardiac
perfus
paraformaldehyd
fisher
scientif
pb
ph
length
spinal
cord
extend
mm
cranial
mm
caudal
site
implant
cut
transvers
block
process
preserv
craniocaud
sequenc
orient
altern
tissu
block
process
resin
cryostat
section
analyz
blind
fashion
resin
section
use
determin
area
ventral
later
column
number
demyelin
remyelin
normal
myelin
axon
cryostat
section
use
determin
spread
brduprelabel
transplant
cell
differenti
profil
resin
section
odd
number
block
post
fix
glutaraldehyd
fisher
scientif
expos
oso
electron
microscopi
scienc
fort
washington
pa
dehydr
ascend
alcohol
embed
spurr
resin
electron
microscopi
scienc
accord
standard
protocol
transvers
semithin
section
cut
cranial
face
block
stain
alkalin
toluidin
blue
cover
slip
examin
light
microscopi
olympu
microscop
use
olympu
microsuit
softwar
total
area
ventral
later
column
measur
object
averag
test
perform
compar
area
ventral
later
column
transplant
nontranspl
anim
state
myelin
determin
assess
thick
myelin
sheath
relat
axon
diamet
guy
et
al
hildebrand
hahn
demyelin
remyelin
normal
myelin
axon
count
within
area
total
tissu
section
use
object
optic
zoom
repres
approxim
total
area
remyelin
within
transplant
anim
determin
measur
total
area
remyelin
tissu
section
block
anim
use
object
averag
area
anim
group
quantit
assess
conduct
throughout
region
extend
mm
cranial
mm
caudal
implant
site
number
demyelin
axon
remyelin
axon
total
number
axon
normal
myelin
plu
demyelin
plu
remyelin
axon
percentag
remyelin
axon
number
remyelinatednumb
total
axon
determin
four
region
tissu
block
averag
averag
across
anim
within
group
tissu
block
test
perform
compar
valu
transplant
nontranspl
group
determin
whether
number
remyelin
axon
anim
correl
total
number
axon
count
area
remyelin
total
axon
count
averag
among
four
count
area
block
anim
correl
coeffici
two
valu
determin
transplant
nontranspl
group
statist
analys
conduct
use
spss
softwar
cryostat
section
even
number
block
cryoprotect
sucros
solut
pb
embed
oct
fisher
scientif
frozen
section
transvers
plane
jung
leica
cryostat
antibrdu
stain
brdu
stain
section
wash
pb
expos
formamid
sigmaaldrich
hydrochlor
acid
fisher
scientif
min
dna
denatur
follow
exposur
h
pb
incub
overnight
room
temperatur
rat
antibrdu
polyclon
antibodi
accur
chemic
scientif
corpor
dilut
ng
secondari
antibodi
biotinyl
goat
antirat
heavi
light
chain
igg
sigmaaldrich
vectastain
abc
vector
laboratori
vector
laboratori
use
signal
visual
number
brduposit
cell
count
three
section
apart
tissu
block
anim
use
olympu
microsuit
softwar
averag
number
brduposit
cell
within
correspond
block
anim
within
group
averag
brdu
doubl
stain
section
wash
pb
expos
hydrochlor
acid
fisher
scientif
min
dna
denatur
primari
antibodi
rat
antibrdu
accur
chemic
scientif
corpor
mous
oncogen
research
product
san
diego
ca
dilut
bovin
serum
albumin
appli
slide
overnight
room
temperatur
slide
rins
three
time
pb
incub
min
bovin
serum
albumin
secondari
antibodi
alexa
goat
antirat
goat
antimous
igg
hl
dilut
bovin
serum
albumin
vector
laboratori
appli
incub
h
room
temperatur
trypan
blue
analysi
indic
approxim
viabl
cell
obtain
postnat
day
mous
float
cell
cluster
reach
approxim
diamet
day
cultur
fig
day
cluster
either
dissoci
transplant
anim
transfer
adher
substrat
absenc
growth
factor
grown
addit
day
assay
differenti
potenti
earli
h
transfer
cell
cluster
adher
substrat
concomit
growth
factor
withdraw
cell
start
spread
adher
cluster
day
display
complex
cellular
morpholog
fig
day
growth
adher
substrat
oligodendrocyt
astrocyt
could
identifi
morpholog
immunolabel
oligodendrocyt
display
multipolar
morpholog
membran
extens
galc
immunoreact
fig
wherea
astrocyt
display
flat
stellat
morpholog
gfap
immunoreact
fig
neun
immunoreact
neuron
fig
immunoreact
microglia
result
shown
detect
noprimari
antibodi
control
stain
chamber
posit
stain
differ
cell
type
often
occupi
discret
region
cultur
dish
total
hoechstposit
cell
count
follow
analys
quantif
immunolabel
cell
indic
f
rang
median
total
cell
popul
brdu
immunoreact
follow
overnight
puls
fig
differenti
protocol
yield
f
oligodendrocyt
rang
median
f
astrocyt
rang
median
f
cell
type
rang
median
includ
neun
neuron
microglia
hoechstposit
cell
identifi
immunostain
test
fig
differ
observ
viabil
differenti
brdulabel
unlabel
cell
transplant
glialcommit
progenitor
label
brdu
implant
surviv
colon
long
length
spinal
cord
surviv
period
fig
differenti
matur
oligodendrocyt
fig
brdulabel
cell
detect
mm
cranial
mm
caudal
site
implant
extent
tissu
examin
extend
throughout
transvers
plane
spinal
cord
primarili
within
white
matter
tract
number
brdulabel
cell
greatest
around
site
implant
fell
sharpli
mm
either
side
site
implant
brdulabel
cell
absent
nontranspl
anim
fig
noprimari
antibodi
control
stain
transplant
anim
nontranspl
anim
infect
mhv
develop
demyelin
diseas
accompani
mononuclear
cell
infiltr
widespread
myelin
destruct
progress
degener
cn
survivor
fleme
et
al
hare
perlman
liu
et
al
stohlman
et
al
systemat
random
analys
fig
indic
numer
demyelin
axon
present
fig
e
g
among
vacuol
myelin
debri
activ
macrophag
lymphocyt
necrot
cell
throughout
region
spinal
cord
examin
indic
ongo
pathogenesi
number
demyelin
axon
significantli
differ
p
transplant
nontranspl
anim
fig
like
mhv
ongo
demyelin
diseas
gener
similar
number
newli
demyelin
axon
nontranspl
transplant
anim
number
fig
percentag
g
quantif
cell
type
day
growth
adher
substrat
absenc
growth
factor
indic
differenti
protocol
yield
f
oligodendrocyt
f
astrocyt
f
cell
type
includ
neun
neuron
microglia
hoechstposit
cell
identifi
immunostain
test
error
bar
repres
standard
deviat
magnif
b
magnif
c
magnif
e
magnif
f
fig
remyelin
axon
nontranspl
anim
significantli
lower
p
transplant
anim
compos
less
total
number
axon
count
fig
normal
myelin
axon
exceedingli
rare
time
point
control
anim
inject
salin
develop
clinic
histopatholog
deficit
transplant
glialcommit
progenitor
result
widespread
remyelin
fig
remyelin
axon
identifi
characterist
thin
elin
sheath
fig
f
h
appear
aggreg
distribut
throughout
dorsal
ventral
later
column
among
demyelin
axon
remyelin
extend
mm
cranial
mm
caudal
implant
site
six
seven
transplant
anim
count
remyelin
axon
throughout
region
extend
mm
cranial
mm
caudal
implant
site
extent
quantif
fig
indic
region
remyelin
contain
remyelin
axon
fig
normal
myelin
axon
exceedingli
rare
time
point
note
tissu
block
number
remyelin
axon
fig
plu
number
demyelin
axon
fig
approxim
total
number
axon
fig
one
transplant
anim
contain
remyelin
axon
similar
nontranspl
anim
p
immunohistolog
analysi
anim
reveal
contain
brduposit
cell
observ
tumor
teratoma
nonneuron
tissu
format
transplant
recipi
observ
qualit
differ
schwann
cell
presenc
remyelin
transplant
nontranspl
anim
count
total
number
axon
normal
myelin
demyelin
remyelin
within
region
extend
mm
cranial
mm
caudal
transplant
site
extent
spinal
cord
examin
suggest
transplant
anim
significantli
axon
p
within
ventral
later
column
compar
nontranspl
anim
fig
h
area
measur
ventral
later
column
reveal
signific
differ
anim
within
transplant
nontranspl
group
p
test
howev
twosampl
test
power
analysi
indic
experiment
n
per
group
insuffici
conclud
statist
signific
differ
group
nonetheless
data
suggest
higher
number
total
axon
within
transplant
anim
result
tissu
shrinkag
transplant
anim
comparison
total
number
axon
number
remyelin
axon
anim
within
transplant
group
indic
statist
signific
correl
two
valu
r
p
indic
greater
degre
axon
spare
correl
greater
degre
remyelin
transplant
anim
surviv
durat
experi
nontranspl
anim
develop
clinic
diseas
typic
character
waddl
gait
partial
hindlimb
weak
day
postinfect
progress
complet
hindlimb
paralysi
day
postinfect
persist
durat
experi
fig
control
salineinject
anim
display
normal
locomotor
behavior
throughout
durat
experi
anim
score
transplant
glialcommit
progenitor
result
signific
improv
locomotor
abil
fig
remyelin
extend
mm
cranial
mm
caudal
implant
site
arrow
transplant
anim
extent
tissu
examin
significantli
greater
degre
remyelin
nontranspl
anim
everi
point
examin
p
c
throughout
region
total
number
axon
ventral
later
column
transplant
anim
remyelin
remyelin
nontranspl
anim
significantli
less
everi
point
examin
p
total
number
axon
within
white
matter
transplant
anim
approxim
total
number
axon
within
similar
region
nontranspl
anim
p
point
suggest
remyelin
associ
axon
spare
error
bar
repres
standard
deviat
fig
transplant
glialcommit
progenitor
cell
result
improv
locomotor
abil
transplant
anim
demonstr
signific
improv
p
locomotor
abil
begin
day
transplant
arrow
day
induct
diseas
transplant
anim
walk
waddl
gait
partial
hindlimb
weak
wherea
nontranspl
anim
demonstr
complet
hindlimb
paralysi
error
bar
repres
standard
deviat
transplant
anim
complet
hindlimb
paralysi
time
transplant
six
seven
transplant
anim
demonstr
signific
p
improv
locomotor
abil
begin
day
transplant
progress
weightsupport
waddl
locomot
partial
hindlimb
weak
one
transplant
anim
demonstr
improv
locomotor
abil
postmortem
analysi
anim
reveal
contain
brduposit
transplant
cell
degre
remyelin
significantli
differ
p
nontranspl
anim
cell
replac
strategi
must
contend
fact
differenti
transplant
cell
strongli
influenc
environment
signal
cellular
defici
oper
site
implant
exampl
stem
cell
isol
adult
hippocampu
gener
new
hippocamp
neuron
glia
follow
transplant
hippocampi
anim
cell
gener
olfactori
bulb
neuron
express
appropri
neurotransmitt
phenotyp
follow
transplant
rostral
migratori
stream
glial
cell
follow
transplant
region
cn
normal
gener
neuron
adult
gage
et
al
suhonen
et
al
influenc
present
formid
challeng
cell
replac
strategi
aim
promot
repair
neurodegen
diseas
injuri
due
complex
reactiv
environ
lesion
point
toward
lineag
commit
multipot
cell
transplant
keirstead
differenti
protocol
result
gener
oligodendrocyt
astrocyt
high
yield
respect
postnat
day
deriv
striatal
neural
precursor
fig
support
previou
studi
use
similar
differenti
protocol
benhur
et
al
cellular
migrat
vitro
evid
earli
h
cellular
differenti
vitro
evid
earli
day
transfer
cell
cluster
adher
substrat
concomit
growth
factor
withdraw
assess
migrat
differenti
vivo
undifferenti
prelabel
glialcommit
progenitor
transplant
region
demyelin
mhv
model
ms
intracerebr
inject
strain
mhv
result
initi
viral
replic
ependym
cell
line
ventricl
subsequ
extend
central
canal
gray
white
matter
spinal
cord
infecti
viru
usual
elimin
day
post
infect
complet
clear
acut
encephalomyel
myelin
loss
present
day
extend
rapidli
anterior
funiculi
immunemedi
demyelin
encephalomyel
hindlimb
paralysi
progress
destruct
cn
follow
although
remyelin
take
place
initi
new
foci
demyelin
like
continu
entir
life
mous
fleme
et
al
hare
perlman
lane
et
al
liu
et
al
stohlman
hinton
stohlman
et
al
current
studi
undifferenti
glialcommit
progenitor
transplant
thorac
spinal
cord
mice
fulmin
demyelin
patholog
complet
hindlimb
paralysi
result
mhv
infect
transplant
cell
surviv
durat
posttransplant
period
spread
throughout
mediolater
extent
spinal
cord
well
mm
cranial
mm
caudal
site
implant
extent
tissu
examin
fig
find
demonstr
transplant
progenitor
cell
capabl
extens
migrat
throughout
region
ongo
pathogenesi
surviv
extens
migrat
transplant
gliogen
cell
popul
demonstr
develop
normal
cn
jacqu
et
al
myelindefici
mutant
cn
brustl
et
al
gansmul
et
al
liu
et
al
tontsch
et
al
chemic
demyelin
cn
grove
et
al
inflam
white
matter
tract
eae
model
ms
benhur
et
al
pluchino
et
al
howev
abil
gliogen
cell
popul
surviv
migrat
environ
indic
intact
normal
adult
cn
glial
progenitor
franklin
et
al
oleari
blakemor
transplant
intact
normal
adult
cn
fail
surviv
migrat
cell
place
immedi
vicin
activ
region
demyelin
surviv
factor
elev
hink
franklin
enter
lesion
find
suggest
surviv
extens
migrat
cell
studi
due
part
continu
patholog
throughout
region
migrat
transplant
glialcommit
progenitor
result
extens
remyelin
rang
axon
present
within
randomli
select
region
spinal
cord
fig
vitro
fig
vivo
fig
differenti
profil
cell
presenc
extens
remyelin
transplant
anim
fig
c
presenc
remyelin
throughout
region
transplant
cell
migrat
fig
suggest
remyelin
conduct
transplant
cell
popul
nonetheless
rule
possibl
remyelin
transplant
anim
carri
endogen
cell
may
activ
result
trophic
support
transplant
popul
cumul
axon
loss
recent
demonstr
sever
human
bitsch
et
al
ferguson
et
al
trapp
et
al
rodent
bjartmar
et
al
griffith
et
al
yin
et
al
demyelin
patholog
use
vivo
magnet
reson
imag
stevenson
miller
van
waesbergh
et
al
vivo
magnet
reson
spectroscopi
arnold
et
al
matthew
et
al
morpholog
analysi
brain
section
ferguson
et
al
trapp
et
al
biochem
method
bjartmar
et
al
chronic
demyelin
probabl
caus
axon
loss
bjartmar
trapp
determin
whether
remyelin
associ
axon
spare
current
studi
total
axon
number
determin
within
ventral
later
column
transplant
nontranspl
anim
group
day
induct
diseas
although
area
ventral
later
column
significantli
differ
transplant
nontranspl
group
p
test
total
number
axon
within
ventral
later
column
transplant
remyelin
anim
approxim
number
axon
within
ventral
later
column
nontranspl
anim
fig
furthermor
comparison
total
number
axon
number
remyelin
axon
anim
within
transplant
group
indic
statist
signific
correl
two
valu
r
find
suggest
greater
degre
axon
spare
correl
greater
degre
remyelin
reduc
axon
loss
also
shown
intraven
intrathec
neurospher
transplant
eae
mous
model
ms
pluchino
et
al
data
support
view
chronic
demyelin
caus
axon
loss
suggest
transplantmedi
remyelin
protect
axon
degenerationtransect
studi
requir
determin
molecular
mechan
underli
demyelinationassoci
axon
degenerationtransect
transplant
glialcommit
progenitor
result
signific
improv
locomotor
abil
begin
day
transplant
progress
weightsupport
waddl
locomot
partial
hindlimb
weak
fig
nontranspl
anim
remain
complet
paralyz
throughout
time
period
fig
region
experiment
demyelin
induc
lysolecithin
smith
et
al
smith
et
al
yezierski
et
al
ethidium
bromid
felt
smith
return
secur
axon
conduct
occur
time
spontan
remyelin
transplant
glial
cell
shown
improv
conduct
veloc
nearnorm
valu
myelindefici
rat
utzschneid
et
al
ethidium
bromid
lesion
honmou
et
al
transplant
clonal
neural
cell
intracerebroventricular
system
shiver
mice
birth
result
myelin
host
neuron
process
reduc
symptomat
tremor
anim
yandava
et
al
thu
intrigu
time
cours
behavior
improv
follow
transplant
current
studi
approxim
time
requir
remyelin
pender
et
al
smith
et
al
find
demonstr
transplantmedi
remyelin
possibl
complex
reactiv
environ
mhv
model
multipl
sclerosi
transplantmedi
remyelin
demonstr
region
cn
subject
experiment
demyelin
myelin
mutant
environ
character
clear
cellular
deficit
larg
nonreact
cn
environ
lack
inflamm
thu
transplant
embryon
stem
cellderiv
precursor
brustl
et
al
oligodendrocyt
progenitor
zhang
et
al
postnat
myelindefici
rat
result
differenti
transplant
cell
myelin
oligodendrocyt
astrocyt
multipotenti
psancam
neural
precursor
isol
postnat
rat
brain
shown
differenti
oligodendrocyt
schwann
cell
astrocyt
follow
transplant
complet
remyelin
region
acut
demyelin
adult
rat
induc
ethidium
bromid
inject
xirradi
dorsal
column
white
matter
similarli
transplant
embryon
stem
cell
region
ethidium
bromid
induc
demyelin
adult
rat
spinal
cord
myelindefici
shiver
mutant
mice
result
gener
stem
cellderiv
oligodendrocyt
capabl
myelin
axon
liu
et
al
recent
transplantmedi
remyelin
illustr
eae
model
ms
follow
intraven
intrathec
inject
adult
neural
precursor
cell
pluchino
et
al
find
confirm
extend
outlin
demonstr
intraspin
transplantmedi
remyelin
occur
fulmin
neurodegen
environ
mhv
model
ms
associ
locomotor
improv
abil
glial
cell
prepar
remyelin
model
necessarili
indic
transplant
demyelin
lesion
clinic
diseas
success
stangel
firstli
transplant
cell
may
subject
demyelin
process
led
develop
initi
patholog
notabl
viral
trigger
patholog
mhv
model
ms
larg
clear
day
postinfect
lane
et
al
stohlman
hinton
time
implant
current
studi
secondli
inabl
glial
progenitor
migrat
normal
tissu
oleari
render
less
ideal
remyelin
dispar
foci
demyelin
seen
clinic
diseas
prinea
et
al
thirdli
human
transplant
necessit
human
progenitor
stem
cell
popul
capabl
amplif
myelinogen
although
robust
amplif
human
embryon
stem
cell
achiev
carpent
et
al
reubinoff
et
al
condit
need
differenti
remyelinationcompet
transplant
popul
yet
defin
fourthli
gliotic
environ
clinic
lesion
may
contribut
failur
endogen
remyelin
may
prohibit
transplant
popul
effect
repair
clearli
sever
key
issu
must
address
cellular
replac
strategi
consid
treatment
human
demyelin
patholog
ms
